Electroceutically induced subthalamic high-frequency oscillations and evoked compound activity may explain the mechanism of therapeutic stimulation in Parkinson's disease.

MLA

Ozturk, Musa, et al. “Electroceutically Induced Subthalamic High-Frequency Oscillations and Evoked Compound Activity May Explain the Mechanism of Therapeutic Stimulation in Parkinson’s Disease.” Communications Biology, vol. 4, no. 1, Mar. 2021, p. 393. EBSCOhost, https://doi.org/10.1038/s42003-021-01915-7.

APA

Ozturk, M., Viswanathan, A., Sheth, S. A., & Ince, N. F. (2021). Electroceutically induced subthalamic high-frequency oscillations and evoked compound activity may explain the mechanism of therapeutic stimulation in Parkinson’s disease. Communications Biology, 4(1), 393. https://doi.org/10.1038/s42003-021-01915-7

Chicago

Ozturk, Musa, Ashwin Viswanathan, Sameer A Sheth, and Nuri F Ince. 2021. “Electroceutically Induced Subthalamic High-Frequency Oscillations and Evoked Compound Activity May Explain the Mechanism of Therapeutic Stimulation in Parkinson’s Disease.” Communications Biology 4 (1): 393. doi:10.1038/s42003-021-01915-7.